.jpg){kind=avatar}
Lyfegen raises $5.7m in Series A funding
Switzerland based drug rebate management company raised $5.7m in Series A funding led by TX Ventures.
{
"The market for innovative and personalized treatments is expanding rapidly, but with that comes increasingly complex and costly pricing...…